Samples were sent to prospective buyers for evaluation with price estimate and finally a process was implemented to ensure recovery of Iodine from the waste streams of both Gemcitabine and Finasteride with a potential estimated savings of more than INR 80 million for FY 2013 projected volumes, as an additional benefit apart from effluent reduction. |